Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trialHideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, et al.
Experimental and Molecular Pathology|March 25, 2008
Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiationGuang Yang, Terry L Timme, Koji Naruishi, et al.
The Journal of Biological Chemistry|May 10, 2003
Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cellsTetsuo Fujita, Yoko Kobayashi, Osamu Wada, et al.
The Prostate|September 15, 2017
Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapyHideyasu Tsumura, Hiromichi Ishiyama, Ken-Ichi Tabata, et al.
Chinese Clinical Oncology|June 27, 2025
Rechallenge of immune checkpoint inhibitor after local therapy for immune checkpoint inhibitor-resistant non-small cell lung cancerSatoshi Hirano, Tetsuo Fujita, Hidekazu Takahashi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2014
Multidisciplinary treatment including systemic chemotherapy for a malignant phyllodes tumour of the prostateYasukiyo Murakami, Ken-Ichi Tabata, Atsushi Sugita, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patientsTetsuo Fujita, Bin S Teh, Terry L Timme, et al.
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 11, 2006
[8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer]Ken-Ichi Tabata, Takefumi Satoh, Kazumasa Matsumoto, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh, Bin S Teh, Terry L Timme, et al.
Pageof 11